Literature DB >> 15309975

Progesterone administration fails to protect albino male rats against photostress-induced retinal degeneration.

I Káldi1, A Berta.   

Abstract

PURPOSE: Female patients show better recovery after brain injury and lower incidence of vascular diseases before menopause. The aim of this study was to test the protective effect of female sexual hormones against photostress-induced photoreceptor apoptosis.
METHODS: Five week old male albino Sprague-Dawley rats were injected intraperitoneally with progesterone (60 mg/kg body weight) for 4 days. The control group was injected with the vehicle only (benzyl alcohol). Both groups were halved and one was stressed with light (2700 lux for 24 hours) and the other remained under the original dim cyclic light condition. For functional evaluation, baseline electroretinograms (ERGs) were recorded 7 days before light stress, with follow-up ERGs 5 days after the cessation of light exposure. Animals were sacrificed and their eyes enucleated for histology.
RESULTS: Light exposure caused pronounced decrease in the ERG a- and b-wave amplitudes compared to controls. However, in the light-stressed group, the difference in retinal function between progesterone-treated and nontreated animals was not statistically significant. The thickness of the outer nuclear layer and the length of rod outer and inner segments were significantly reduced in the light-stressed group, indicating loss of rod photoreceptor cells. Progesterone had no neuroprotective effect on rod cell structure.
CONCLUSIONS: The administration of progesterone did not prove to be protective against excessive light-caused retinal degeneration on male albino rats. The role of other sexual steroids and their interaction need to be clarified.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309975     DOI: 10.1177/112067210401400405

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  5 in total

1.  Gender influences cerebral oxygenation after red blood cell transfusion in patients with severe traumatic brain injury.

Authors:  Victoria Arellano-Orden; Santiago R Leal-Noval; Aurelio Cayuela; Manuel Muñoz-Gómez; Carmen Ferrándiz-Millón; Claudio García-Alfaro; Antonio Marín-Caballos; José Ma Domínguez-Roldán; Francisco Murillo-Cabezas
Journal:  Neurocrit Care       Date:  2011-02       Impact factor: 3.210

Review 2.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

3.  The synthetic progestin norgestrel acts to increase LIF levels in the rd10 mouse model of retinitis pigmentosa.

Authors:  Ashleigh M Byrne; Sarah L Roche; Ana M Ruiz-Lopez; Alice C Wyse Jackson; Thomas G Cotter
Journal:  Mol Vis       Date:  2016-03-25       Impact factor: 2.367

Review 4.  Gonadal Hormones and Retinal Disorders: A Review.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco; Giancarlo Panzica
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-02       Impact factor: 5.555

5.  Serum progesterone and retinopathy in male patients with type 2 diabetes: A cross-sectional study.

Authors:  Shengnan Sun; Yahao Wang; Yue Zhou; Wenru Ma; Yajing Huang; Jianxia Hu; Yangang Wang
Journal:  J Diabetes Investig       Date:  2020-12-14       Impact factor: 4.232

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.